Skip to content

Tagepigenomics

Researchers led by UC San Diego develop a non-invasive blood test capable of detecting circulating tumor DNA methylation to identify whether a person has one of the five most prevalent forms of cancers, up to four years before diagnosis. The team states their diagnostic can detect cancer by targeting a limited number of genomic regions aberrantly methylated across different cancer types, allowing it to be used as an inexpensive cancer screen from only a single vial of blood, unlike the more costly ctDNA which works by identifying a legion of inconsistent mutations.

Non-invasive blood test can detect cancer four years before diagnosis.

The leading cause of death worldwide, cancer killed at least 7.6 million people in 2008, accounting for a staggering thirteen percent of all deaths globally. With no signs of abating, … Continue Reading Non-invasive blood test can detect cancer four years before diagnosis.

Translate »